1. Home
  2. CGEM vs REAX Comparison

CGEM vs REAX Comparison

Compare CGEM & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$11.19

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

HOLD

Current Price

$3.96

Market Cap

790.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEM
REAX
Founded
2016
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
790.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CGEM
REAX
Price
$11.19
$3.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
$28.00
$6.33
AVG Volume (30 Days)
1.4M
1.3M
Earning Date
11-06-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,813,907,000.00
Revenue This Year
N/A
$56.57
Revenue Next Year
N/A
$21.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.60
52 Week Low
$5.68
$3.42
52 Week High
$13.33
$5.65

Technical Indicators

Market Signals
Indicator
CGEM
REAX
Relative Strength Index (RSI) 54.68 50.28
Support Level $10.01 $3.92
Resistance Level $13.10 $4.50
Average True Range (ATR) 1.02 0.16
MACD -0.03 0.03
Stochastic Oscillator 33.50 27.27

Price Performance

Historical Comparison
CGEM
REAX

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: